Welcome to our dedicated page for OMEGA HEALTHCARE INVESTORS SEC filings (Ticker: OHI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on OMEGA HEALTHCARE INVESTORS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into OMEGA HEALTHCARE INVESTORS's regulatory disclosures and financial reporting.
Omega Healthcare Investors director Lisa Egbuonu-Davis received a grant of 3,778 shares of common stock as director compensation on June 5, 2026. The award was made via a Restricted Stock Grant Award Agreement at an indicated value of $43.67 per share.
The restricted shares will vest on the date of the company’s 2027 Annual Meeting of Shareholders, approximately one year from the grant date, and will convert to common stock on a one-for-one basis. Following this compensation grant, Egbuonu-Davis directly holds 22,432 shares of Omega Healthcare Investors common stock.
OMEGA HEALTHCARE INVESTORS INC director Anand Kapila K received an equity award in the form of deferred stock units. On the reported date, he was granted 6,205 Deferred Stock Units at no cash cost as an annual restricted stock grant elected to be taken in this form.
Each unit converts into one share of common stock, and related dividends can also be credited as additional units if elected. The units are restricted from transfer or sale until Omega's 2027 Annual Meeting of Shareholders, defined as the vesting date, and will convert into common shares upon separation from service, death, disability, or other specified plan events. Following this grant, he holds 44,992 Deferred Stock Units directly.
OMEGA HEALTHCARE INVESTORS INC director Craig R. Callen reported equity-based compensation and related conversions, with only acquisition-type transactions and no share sales. He received a grant of 9,708 Profits Interest Units (PIUs) on June 5, 2026, representing a contingent right to receive an equal number of OP Units upon vesting and satisfaction of tax-driven economic requirements. On the same date, 11,263 previously granted PIUs vested and converted into 11,263 OP Units. A related transaction shows 11,263 OP Units exercised into common stock equivalents, leaving 74,310 OP Units held directly. The 2026 PIU grant is described as his annual stock grant and will fully vest on the date of the company’s 2027 Annual Meeting of Shareholders, subject to continued service.
Omega Healthcare Investors, Inc. held its 2026 Annual Meeting of Stockholders, where 255,926,290 shares were represented, about 85.93% of shares outstanding as of the record date. Stockholders elected all eight director nominees, ratified Ernst & Young LLP as independent auditor for the year ending December 31, 2026, and approved Omega’s executive compensation on an advisory basis.
The company also updated information on large stockholders. As of April 8, 2026, filings show Vanguard Portfolio Management beneficially owning 27,160,324 shares (9.1% of the class), Vanguard Capital Management 15,689,615 shares (5.3%), and BlackRock, Inc. 31,867,200 shares (10.7%).
PICKETT C TAYLOR reported open-market sale transactions in this Form 4 filing.
Omega Healthcare Investors CEO C. Taylor Pickett reported a redemption of 112,500 OP Units for cash. According to the filing, each OP Unit of OHI Healthcare Properties Limited Partnership was redeemed at $47.94, equal to the 10-day average closing price of the company’s common stock before the redemption notice.
Each OP Unit is redeemable, at the holder’s election, for cash equal to the fair market value of one share of common stock or, at the company’s election, one share of common stock and has no expiration date. After these transactions, Pickett also has OP Units representing an underlying 1,225,003 shares of common stock held directly.
Omega Healthcare Investors is implementing a planned leadership transition, with longtime CEO Taylor Pickett retiring effective October 1, 2026 and stepping down from the Board. President Matthew Gourmand will become CEO and is expected to join the Board on that date. CFO Bob Stephenson will retire effective August 1, 2026, with Chief Accounting Officer Neal Ballew promoted to CFO and Lucas Golem becoming Chief Accounting Officer on the same date.
Pickett and Stephenson each signed transition and consulting agreements. Pickett will receive his 2026 annual incentive un‑prorated, equity vesting through December 31, 2029, company-paid health premiums for up to 18 months, transfer of a supplemental life policy, and a consulting role through at least October 1, 2027 at $20,000 per month. Stephenson will receive benefits consistent with a termination without cause under his employment agreement, plus un‑prorated 2026 incentive, equity vesting through December 31, 2029, transfer of a supplemental life policy and a consulting role through at least August 1, 2027 at $12,000 per month. The company highlights that under Pickett’s 25-year tenure, total shareholder return exceeded 10,000%, the portfolio grew from 258 to 1,124 assets, and market capitalization rose from about $60 million to over $15 billion.
Omega Healthcare Investors Inc ownership filing shows Vanguard Capital Management reports beneficial ownership of 15,689,615 shares of Common Stock, representing 5.30% of the class as reported. The filing lists sole voting power: 2,455,494 and sole dispositive power: 15,689,615; signature dated 04/30/2026.
Omega Healthcare Investors Inc reported that Vanguard Portfolio Management beneficially owned 27,160,324 shares of Common Stock, representing 9.18% of the class. The filing states Vanguard has sole dispositive power over 27,160,324 shares and sole voting power for 37,207 shares.
The Schedule 13G was signed on 04/29/2026 and discloses holdings exercised on behalf of Vanguard funds and managed accounts.
Omega Healthcare Investors reported stronger first‑quarter 2026 results, with higher revenue and earnings while actively recycling assets and managing operator exposure. Total revenues rose to $322.9M from $276.8M a year earlier, driven mainly by rental income growth and new senior housing operating revenue.
Net income available to common stockholders increased to $151.0M, or $0.47 per diluted share, up from $109.0M and $0.33 per share. Operating cash flow improved to $215.5M. Omega invested $126.4M in new real estate, including 13 SNFs in Georgia, and sold four SNFs for $34.5M in proceeds.
The company expanded its held‑for‑sale pool to 19 facilities and post‑quarter sold 12 CommuniCare‑leased facilities in Maryland for $326.3M, reallocating capital while reducing single‑operator concentration. Omega ended the quarter with total assets of $10.23B, net real estate loans of $1.39B, and unsecured borrowings of about $4.44B, including $425M drawn on its revolver.
Omega Healthcare Investors, Inc. reported strong first-quarter 2026 results, with total revenues of $322.9 million versus $276.8 million a year earlier. Net income available to common stockholders rose to $151.0 million, or $0.47 per diluted share, compared with $0.33 per share in 2025.
Nareit FFO reached $249.5 million and Adjusted FFO rose to $259.7 million, while FAD was $246.8 million. Management highlighted that FAD per share increased 9.5% year over year and raised 2026 Adjusted FFO guidance to a range of $3.19–$3.25 per diluted share, moving the midpoint up to $3.22.
Omega completed approximately $250.8 million of new real estate, loan, and unconsolidated investments in Q1 and an additional $75.0 million early in Q2, alongside $34.5 million of asset sales and a planned $479.9 million skilled nursing portfolio disposition. The company ended the quarter with $4.5 billion of debt, $26.1 million of cash, and $1.6 billion of undrawn revolver capacity, and declared a quarterly dividend of $0.67 per share.